Phase
Condition
N/ATreatment
Magstim Rapid2
Clinical Study ID
Ages 18-39 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
FEMALES
Inclusion Criteria:
Ages 18-39 years
Eumenorrheic (regular monthly cycles of 24-35 days)
Moderately active (less than 7 hours of vigorous physical activity per week)
History of pregnancy is allowed if patient is in post-lactation phase
Exclusion
Exclusion Criteria:
History of musculoskeletal or orthopedic injury of the spine, hip, knee, ankle orfoot
History of neurological injury of the peripheral or central nervous system
Current smoker
History of disordered eating
History of stress fracture in the lower limb
History of a connective tissue disorder (Marfan's syndrome, Ehlers-Danlos disease)
Pacemaker, metal implants in the head and spine region
Pregnancy
On a hormonal contraceptive regimen (oral, transdermal or vaginal)
History of menstrual dysfunction (primary or secondary amenorrhea, oligomenorrhea,anovulatory cycles, polycystic ovarian disease)
Started or stopped taking oral contraceptives within the previous 6 months
Exercise vigorously more than 7 hours per week or currently participating incompetitive level sports.
MALES
Inclusion Criteria:
Ages 18-39
Moderately active (less than 7 hours of vigorous physical activity per week)
Exclusion Criteria:
History of musculoskeletal or orthopedic injury of the spine, hip, knee, ankle orfoot
History of neurological injury of the peripheral or central nervous system
Current smoker
History of disordered eating
History of stress fracture in the lower limb
History of a connective tissue disorder (Marfan's syndrome, Ehlers-Danlos disease)
Pacemaker, metal implants in the head and spine region
Study Design
Connect with a study center
University of Texas Southwestern Medical Center
Dallas, Texas 75390
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.